RE: FEB.20-22 , 2008Good point Brox! And if you have not looked at the interim results news item posted on the company website you should have a look. The results on the first 4 patients were not only good they were excellent. I expect more of the same from the full 12 patient study....and they have already gone ahead into the phase IIb, which they would not have done if the results were not good in the phase IIa study! The general market sucks....this company has been flying under the radar...but I expect great results to be announced at the International Stroke Conference(FEB.20-22) and I would not be surprised to see some international investment to follow. If you look at the schedule of events you will see a large number of of Bio-partnering type meetings. And stroke,TBI and MS indication studies will be underway soon and these are all areas that need better treatments with market potential of over $10 billion each.